## MOH: Molina Healthcare, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 1.9% below STRENGTH zone (4.0-10.0%); PEG 2.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($137.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. MOH Deadline Today: MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit**
- Source: Morningstar | 20251203T150925 | Bearish | Relevance: 100%
- The Rosen Law Firm reminds investors who purchased Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025, and July 23, 2025, of the December 2, 2025, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance, leading to investors suffering damages. Investors can join the class action to potentially recover compensation without upfront fees.

**2. MOH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC**
- Source: GlobeNewswire | 20251202T120000 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Molina Healthcare, Inc. (NYSE: MOH) and its officers. The lawsuit alleges that Molina Healthcare failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance, leading to substantial losses for investors. Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, are encouraged to join the lawsuit and have until December 2, 2025, to request to be appointed as lead plaintiff.

**3. December 2, 2025 Deadline Approaching: Join Class Action Against Molina Healthcare, Inc. (MOH) - Contact Levi & Korsinsky**
- Source: KLAS 8 News Now | 20251202T104200 | Bearish | Relevance: 100%
- Levi & Korsinsky LLP is announcing a class action securities lawsuit against Molina Healthcare, Inc. (NYSE: MOH) with a deadline of December 2, 2025, for investors to join. The lawsuit alleges that Molina Healthcare made false and misleading statements regarding its medical cost trend assumptions and financial guidance, leading to a drop in stock price. Shareholders who suffered losses between February 5, 2025, and July 23, 2025, are encouraged to contact the firm for more information on rights to recovery.

**4. Portnoy Law Firm Announces Class Action on Behalf of Molina Healthcare, Inc. Investors**
- Source: GlobeNewswire | 20251202T090000 | Bearish | Relevance: 100%
- The Portnoy Law Firm has announced a class action lawsuit against Molina Healthcare, Inc. on behalf of investors who purchased securities between February 5, 2025, and July 23, 2025. The lawsuit stems from Molina's revised financial guidance, which saw significant cuts to its 2025 adjusted earnings per share and GAAP net income due to unexpected medical cost pressures. Investors are encouraged to contact the law firm to discuss their legal rights and potential claims.

**5. Investors who lost money on Molina Healthcare, Inc.(MOH) should contact The Gross Law Firm about pending Class Action - MOH**
- Source: Sahm | 20251202T000830 | Bearish | Relevance: 100%
- The Gross Law Firm is notifying shareholders of Molina Healthcare, Inc. (NYSE: MOH) about a pending class action lawsuit. Shareholders who purchased MOH shares between February 5, 2025, and July 23, 2025, and suffered losses are encouraged to contact the firm by the December 2, 2025 deadline to register for the class action. The lawsuit alleges that Molina Healthcare made misleading statements regarding its medical cost trend assumptions and financial guidance.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (9.4%): bears positioning against stock.
2. Long-term trend broken: trading 37.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.54 signals overvaluation risk, limited margin of safety. Forward P/E 9.1x attractive for 18% earnings growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.9B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.54 |
| Forward P/E | 9.1 |
| Current P/E | 10.7 |
| YoY Growth | 18.1% |
| EPS Direction | None |

### Technicals

MRS_20 stable at 1.9% (minimal 5-day change). Below STRENGTH zone by 2.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. AM_20 at 3.9% shows strong absolute momentum above own 20MA. Below SMA200 (0.63x), long-term trend not supportive. MACD histogram positive (2.44), confirming momentum. RSI neutral at 48. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.93% (CS: 70) | Neutral |
| RSI_14 | 47.8 | Neutral |
| MACD Histogram | 2.44 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 0.889x | Below |
| vs SMA200 | 0.626x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $149.09
- **Stop Loss:** $137.13 (8.0% risk)
- **Target:** $161.05 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $11,778.11
- **Portfolio %:** 11.78%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*